CMA slaps pharma firms with £260m in fines for ... - Thyroid UK

Thyroid UK

139,077 members163,219 posts

CMA slaps pharma firms with £260m in fines for hiking prices for NHS for hydrocortisone tablets.

AnneEvo profile image
4 Replies

This is about hiking the price of 'life saving' hydrocortisone tablets by over 10,000 per cent. Interestingly the two companies named here are Accored and Auden McKenzie which operated under the name Actavis UK in 2015. (Actavis UK was then bought by Accord Healthcare).

The watchdog boss says, 'Our fine serves as a warning to any other drug firm planning to exploit the NHS.' What about those already exploiting the NHS?

It's a pity they haven't yet; as far as I know; slapped them with a fine for the hiking of Levo prices.

cityam.com/cma-slaps-pharma...

Written by
AnneEvo profile image
AnneEvo
To view profiles and participate in discussions please or .
Read more about...
4 Replies
shaws profile image
shawsAdministrator

It's about time that prices were checked. If T3 can be bought abroad at a very low price, why is it so high in the UK which is extortionate and was the perfect excuse to have it withdrawn from being prescribed.

"dailymail.co.uk/health/arti...

AnneEvo profile image
AnneEvo in reply to shaws

It's so frustrating reading that article. The CMA criticised the huge price increase and yet didn't slap a fine on pharmaceutical company or companies as they have done for hydrocortisone.

TaraJR profile image
TaraJR

From the Evening Standard article: "The CMA said Auden Mckenzie’s decision to raise prices for de-branded drugs meant that the NHS had no choice but to pay huge sums of taxpayers’ money for life-saving medicines.”

WHY did the NHS have no choice? There must be other suppliers abroad who they could buy from? Does NHS have no free will?!

Josephineinamachine profile image
Josephineinamachine in reply to TaraJR

I’d like to know this too! Is it about big company takeovers, patents, paying other smaller companies not to compete…?

If T3 can be made so cheaply there is a great big similar stitch up somewhere. The NHS won’t prescribe ‘expensive’ T3 to patients who won’t need to pay for it because they’re exempt from prescription charges.

I wish I had the brain power to understand…

You may also like...

Advanz Pharma fined £100m by CMA for liothyronine price inflation

prescribed on the NHS yet?...

Big Pharma fined for inflating prices to NHS

theguardian.com/business/2021/jul/30/drug-firm-that-hiked-prices-by-6000-paid-shareholders-400m...

CMA fines Advanz and others for over pricing of liothyronine

and Markets Authority (CMA) has fined Advanz and others for hiking up the price of liothyronine by...

CMA Advanz Liothyronine Fine: Pain aggravation: the human cost of medicine price hikes

human cost of medicine price hikes After Advanz’s £100m fine over the price of its...

'Extortionate' prices add £260m to NHS drug bill